HW

Heather Wasserman

COO/CBO

Remix Therapeutics

Cambridge, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Remix Therapeutics
Industry
research
Employees
71.0
Seniority
C suite
Annual Revenue
3200000.0
Total Funding
211000000.0
Latest Funding
Other

Technologies

Gmail Mimecast Outlook Google Apps Google Cloud Hosting WP Engine Greenhouse.io Mobile Friendly Google Tag Manager Google Font API Nginx WordPress.org Remote Basis AI

Keywords

biotechnology research rna processing small molecule therapies gene expression modulation therapeutic development clinical-stage biotechnology cancer treatment drug discovery platform anti-leukemic activity rna modulators oncogenic transcription factors splicing regulation alternative splicing preclinical models phase 1 clinical trials disease modification medical research biotechnology innovation druggable targets medicinal chemistry high-throughput screening compound optimization adenoid cystic carcinoma acute myeloid leukemia neurodegenerative diseases clinical development programs patient-centric approach mrna degradation biomolecular sciences precision medicine therapeutic options high unmet medical needs remaster platform transcriptome database genetic toolkit splicing network cancer biomarker modulating gene expression biopharmaceuticals therapeutic candidates drug design patient outcomes innovative therapeutics collaborative research targeted therapies cell-based screening therapeutic interventions

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans